Argenx Se (ARGX) Goodwill & Intangibles (2015 - 2026)

Argenx Se (ARGX) posted quarterly Goodwill & Intangibles of $266.0 million for Q2 2026, down 99.92% year-on-year from $352.3 billion in Q2 2025, and down 35.21% on a QoQ basis from $410.6 million in Q4 2025.

Argenx Se (ARGX) Goodwill & Intangibles (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Goodwill & Intangibles for 12 consecutive years, with $266.0 million the latest figure, recorded in Q2 2026.

  • Quarterly Goodwill & Intangibles fell 99.92% year-over-year to $266.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $266.0 million (down 99.92% YoY) and the FY2025 annual result came in at $7.5 billion, up 22.81% from the prior year.
  • Goodwill & Intangibles retreated to $266.0 million in Q2 2026 per ARGX's latest filing, from $410.6 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for ARGX reached as high as $352.3 billion in Q2 2025 and fell as low as $256.8 million in Q4 2023.
  • A 5-year average of $39.4 billion and a median of $305.8 million in 2022 frame the typical range for Goodwill & Intangibles.
  • Annual changes were most pronounced in 2025 — Goodwill & Intangibles soared 130048.98% — and 2026, when it tumbled 99.92%.
  • Year by year, Goodwill & Intangibles stood at $305.8 million in 2022, then declined by 16.03% to $256.8 million in 2023, then gained by 20.06% to $308.3 million in 2024, then jumped by 33.18% to $410.6 million in 2025, then tumbled by 35.21% to $266.0 million in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $266.0 million, $410.6 million, and $352.3 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 266.00 Mn
Dec 31, 2025 410.57 Mn
Jun 30, 2025 352.33 Bn
Dec 31, 2024 308.28 Mn
Jun 30, 2024 270.71 Mn
Dec 31, 2023 256.77 Mn
Jun 30, 2023 319.90 Mn
Dec 31, 2022 305.80 Mn
Jun 30, 2022 299.99 Mn
Dec 31, 2021 303.37 Mn
Jun 30, 2021 308.33 Mn
Dec 31, 2020 155.23 Mn
Jun 30, 2020 46.59 Mn
Dec 31, 2019 45.70 Mn
Jun 30, 2019 40.37 Mn
Dec 31, 2018 63,725.44
Jun 30, 2018 11,545.68
Dec 31, 2017 142,877.76
Jun 30, 2017 17,318.52
Dec 31, 2016 24,534.56